Clinic
Alegent Creighton Health
Alegent Creighton Health was paid $3.01M by Medicaid between Jan 2018 and Oct 2024, across 80 billing codes. Its largest line is 99283, emergency room visit (moderate) — 26% of everything it billed.
33Billing provider infoALEGENT CREIGHTON HEALTH
PAPILLION, NE 68046
PAPILLION, NE 68046
33aNPI1215006101assigned 11/07/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$3.01M
24GClaims73,224
24DCodes billed80
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Nebraska
Rank by total paid#7 of 35
Median peer was paid$190K
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KUIPER, EVERT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,837 | $365K | |
| 2019 | 7,158 | $389K | |
| 2020 | 6,970 | $289K | |
| 2021 | 18,775 | $580K | |
| 2022 | 22,819 | $861K | |
| 2023 | 8,582 | $430K | |
| 2024incomplete | 2,083 | $98K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 5,607 | 5,202 | $789K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 22% | 4,212 | 3,789 | $668K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 2,062 | 1,822 | $323K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 7.7% | 4,215 | 1,272 | $233K |
| 96361 | Intravenous infusion, hydration; each additional hour | 6.9% | 1,082 | 868 | $207K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.9% | 751 | 680 | $179K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.8% | 801 | 705 | $146K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.6% | 856 | 806 | $77K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.2% | 661 | 595 | $67K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.9% | 1,185 | 391 | $58K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.0% | 219 | 177 | $31K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,770 | 2,309 | $25K |
68 more codes
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 336 | $20K |
| 80050 | General health panel | <1% | 1,310 | $19K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,966 | $18K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,027 | $17K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,312 | $16K |
| 80053 | Comprehensive metabolic panel | <1% | 4,179 | $11K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,521 | $9K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 98 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,790 | $7K |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | <1% | 20 | $7K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 36 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,525 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 403 | $6K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 87 | $6K |
| 84484 | <1% | 2,229 | $6K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 121 | $5K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 29 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,506 | $5K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,793 | $5K |
| J3490 | Unclassified drugs | <1% | 5,242 | $4K |
| 84703 | <1% | 938 | $4K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 15 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 833 | $2K |
| 83690 | <1% | 1,507 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 209 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 12 | $2K |
| 81001 | <1% | 1,395 | $2K | |
| 93971 | <1% | 13 | $2K | |
| 76830 | Ultrasound, transvaginal | <1% | 31 | $1K |
| 97161 | <1% | 251 | $605.12 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 365 | $593.52 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 28 | $587.50 |
| 81003 | <1% | 847 | $545.43 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 31 | $407.64 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 17 | $397.68 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 187 | $331.80 |
| 81025 | <1% | 638 | $327.43 | |
| 87081 | <1% | 16 | $240.99 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 438 | $183.03 |
| 96376 | <1% | 242 | $172.80 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 934 | $110.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 556 | $78.67 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 83 | $55.21 |
| 82962 | <1% | 475 | $43.39 | |
| J2704 | Injection, propofol, 10 mg | <1% | 276 | $34.32 |
| 83605 | <1% | 331 | $30.43 | |
| 87077 | <1% | 12 | $18.50 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 3,087 | $17.68 |
| 85610 | <1% | 114 | $10.68 | |
| 87186 | <1% | 12 | $9.25 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 310 | $7.62 |
| 85379 | <1% | 61 | $5.17 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 136 | $1.94 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 62 | $0.00 |
| A9270 | Non-covered item or service | 0% | 895 | $0.00 |
| 82077 | 0% | 358 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 61 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 52 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 15 | $0.00 |
| 83735 | 0% | 27 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 53 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 64 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 48 | $0.00 |
| 87040 | 0% | 52 | $0.00 | |
| 80143 | 0% | 66 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 43 | $0.00 |
| 80179 | 0% | 65 | $0.00 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKUIPER, EVERT (CEO - CHI HEALTH)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.